Perspective Therapeutics (CATX) Interest & Investment Income (2010 - 2026)
Perspective Therapeutics recorded quarterly Interest & Investment Income of $2.2 million in Q1 2026, up 36.12% quarter-over-quarter from $1.6 million in Q4 2025, and down 7.84% year-over-year from $2.4 million in Q1 2025.
Perspective Therapeutics' Interest & Investment Income history runs 17 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 7.84% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $7.9 million (down 32.18% YoY), while the FY2025 annual figure was $8.1 million, down 22.83% from the prior year.
- Interest & Investment Income came in at $2.2 million for Q1 2026 at Perspective Therapeutics, up from $1.6 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $3.6 million in Q3 2024 to a low of $28000.0 in Q2 2022.
- A 5-year average of $1.3 million and a median of $1.2 million in 2024 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income tumbled 88.95% in 2023 and soared 4169.35% in 2024, its largest moves.
- Perspective Therapeutics' Interest & Investment Income stood at $561000.0 in 2022, then sank by 88.95% to $62000.0 in 2023, then jumped by 4169.35% to $2.6 million in 2024, then tumbled by 39.03% to $1.6 million in 2025, then soared by 36.12% to $2.2 million in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $2.2 million, $1.6 million, and $2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -25.76 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.20 Mn |
| Dec 31, 2025 | 1.61 Mn |
| Sep 30, 2025 | 1.96 Mn |
| Jun 30, 2025 | 2.16 Mn |
| Mar 31, 2025 | 2.38 Mn |
| Dec 31, 2024 | 2.65 Mn |
| Sep 30, 2024 | 3.58 Mn |
| Jun 30, 2024 | 3.08 Mn |
| Mar 31, 2024 | 1.21 Mn |
| Dec 31, 2023 | 62,000.00 |
| Sep 30, 2023 | 204,000.00 |
| Jun 30, 2023 | 294,000.00 |
| Mar 31, 2023 | 374,000.00 |
| Dec 31, 2022 | 561,000.00 |
| Sep 30, 2022 | 140,000.00 |
| Jun 30, 2022 | 28,000.00 |
| Mar 31, 2022 | 29,000.00 |
| Dec 31, 2021 | 31,000.00 |
| Sep 30, 2021 | 31,000.00 |
| Mar 31, 2021 | 21,000.00 |
| Dec 31, 2020 | 5,000.00 |
| Sep 30, 2020 | 1,000.00 |
| Jun 30, 2020 | 1,000.00 |
| Mar 31, 2020 | 3,000.00 |
| Dec 31, 2019 | 6,000.00 |
| Sep 30, 2019 | 20,000.00 |
| Jun 30, 2019 | 49,000.00 |
| Mar 31, 2019 | 34,000.00 |
| Dec 31, 2018 | 15,000.00 |
| Sep 30, 2018 | 10,000.00 |
| Jun 30, 2018 | 12,000.00 |
| Mar 31, 2018 | 7,000.00 |
| Dec 31, 2017 | 5,000.00 |
| Sep 30, 2017 | 6,000.00 |
| Jun 30, 2017 | 29,000.00 |
| Mar 31, 2017 | 29,000.00 |
| Dec 31, 2016 | 29,000.00 |
| Sep 30, 2016 | 30,000.00 |
| Jun 30, 2016 | 52,000.00 |
| Mar 31, 2016 | 54,000.00 |
| Dec 31, 2015 | 56,000.00 |
| Sep 30, 2015 | 56,000.00 |
| Jun 30, 2015 | 68,991.00 |
| Mar 31, 2015 | 68,954.00 |
| Dec 31, 2014 | 72,360.00 |
| Sep 30, 2014 | 72,695.00 |
| Jun 30, 2014 | 10,722.00 |
| Mar 31, 2014 | 556.00 |
| Dec 31, 2013 | 481.00 |
| Sep 30, 2013 | 354.00 |
| Jun 30, 2013 | 309.00 |
| Mar 31, 2013 | 83.00 |
| Dec 31, 2012 | 128.00 |
| Sep 30, 2012 | 144.00 |
| Jun 30, 2012 | 148.00 |
| Mar 31, 2012 | 144.00 |
| Dec 31, 2011 | 268.00 |
| Sep 30, 2011 | 187.00 |
| Jun 30, 2011 | 493.00 |
| Mar 31, 2011 | 848.00 |
| Dec 31, 2010 | 979.00 |
| Sep 30, 2010 | 1,061.00 |